Loading data for SNDX — first visit, this takes a few seconds.
Syndax Pharmaceuticals, Inc. (SNDX)
NasdaqGS: SNDX
· Real-Time Price · USD
19.54
-0.62 (-3.08%)
At close: Aug 31, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Syndax Pharmaceuticals, Inc. (SNDX) Stock Price, Analysis & Data
No data available
| Bid | 14.19 |
| Market Cap | 1.72B |
| Revenue (ttm) | 252M |
| Net Income (ttm) | -221M |
| 0.37 | |
| -2.48 | |
| n/a | |
| -23.64 | |
| P/B (ttm) | 114.14 |
| P/S (ttm) | 6.78 |
| Earnings Date | Nov 2, 2026 |
| Ask | 24.94 |
| Volume | 1,042,612 |
| Avg. Volume (20D) | 1,794,958 |
| Open | 19.98 |
| Previous Close | 20.16 |
| Day's Range | 19.47 - 20.05 |
| 52-Week Range | 12.99 - 25.59 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SNDX
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the trea...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 2, 2016
Employees 298
Stock Exchange NasdaqGS
Ticker Symbol SNDX
Website https://syndax.com
Financial Performance
In 2025, Syndax Pharmaceuticals's revenue was 172.35M, an increase of 627.84% compared to the previous year's 23.68M. Earnings were -285.42M, a decrease of -10.46%.
Financial StatementsEarnings Surprise
Syndax Pharmaceuticals has released their quarterly earnings on Aug 4, 2026:
- Revenue of $72.79M misses estimates by $0, with 91.76% YoY growth.
- EPS of -0.55 misses estimates by -0.11, with 33.73% YoY growth.
Syndax Pharmaceuticals, Inc. is scheduled to release its earnings on Nov 2, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2